(Q74835926)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Medical-claims databases in the design of a health-outcomes comparison of quetiapine ('Seroquel') and usual-care antipsychotic medication (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

W W Hong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

I W Rak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

V T Ciuryla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

A M Wilson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J W Kylstra

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

H Y Meltzer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

W T Carpenter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

A Lehman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

L A Arvanitis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

published in

Schizophrenia Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

51-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

1 reference

7 January 2021

Mental health cost models. Refinements and applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

1 reference

7 January 2021

Who became revolving door patients? Findings from a nation-wide cohort of first time admitted psychiatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

The new revolving-door patients: results from a national cohort of first admissions

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Measuring the economic costs of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Why do schizophrenic patients refuse to take their drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

Cost of relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900040-1

7 January 2021

10.1016/S0920-9964(98)00040-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9690334%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference